Brief: Unichem Laboratories Gets EIR For Post Marketing Adverse Drug Experience Inspection
Nov 26 (Reuters) - Unichem Laboratories Ltd UNLB.NS :
* UNICHEM LABORATORIES GETS EIR FOR POST MARKETING ADVERSE
DRUG
EXPERIENCE INSPECTION CONDUCTED BY USFDA FROM JUNE 25 TO JUNE 29
Source text - https://bit.ly/2AnTACZ
Further company coverage: UNLB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium